1. Home
  2. CASI vs UONEK Comparison

CASI vs UONEK Comparison

Compare CASI & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • UONEK
  • Stock Information
  • Founded
  • CASI 1991
  • UONEK 1980
  • Country
  • CASI China
  • UONEK United States
  • Employees
  • CASI N/A
  • UONEK N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • UONEK Broadcasting
  • Sector
  • CASI Health Care
  • UONEK Consumer Discretionary
  • Exchange
  • CASI Nasdaq
  • UONEK Nasdaq
  • Market Cap
  • CASI 29.0M
  • UONEK 32.0M
  • IPO Year
  • CASI 1996
  • UONEK N/A
  • Fundamental
  • Price
  • CASI $1.33
  • UONEK $0.63
  • Analyst Decision
  • CASI Strong Buy
  • UONEK
  • Analyst Count
  • CASI 1
  • UONEK 0
  • Target Price
  • CASI $4.00
  • UONEK N/A
  • AVG Volume (30 Days)
  • CASI 287.9K
  • UONEK 12.6K
  • Earning Date
  • CASI 08-15-2025
  • UONEK 08-07-2025
  • Dividend Yield
  • CASI N/A
  • UONEK N/A
  • EPS Growth
  • CASI N/A
  • UONEK N/A
  • EPS
  • CASI N/A
  • UONEK N/A
  • Revenue
  • CASI $31,368,000.00
  • UONEK $437,499,000.00
  • Revenue This Year
  • CASI N/A
  • UONEK N/A
  • Revenue Next Year
  • CASI N/A
  • UONEK N/A
  • P/E Ratio
  • CASI N/A
  • UONEK N/A
  • Revenue Growth
  • CASI 8.39
  • UONEK N/A
  • 52 Week Low
  • CASI $1.10
  • UONEK $0.44
  • 52 Week High
  • CASI $7.67
  • UONEK $1.74
  • Technical
  • Relative Strength Index (RSI)
  • CASI 28.60
  • UONEK 55.70
  • Support Level
  • CASI $1.10
  • UONEK $0.63
  • Resistance Level
  • CASI $2.07
  • UONEK $0.71
  • Average True Range (ATR)
  • CASI 0.28
  • UONEK 0.06
  • MACD
  • CASI -0.06
  • UONEK -0.00
  • Stochastic Oscillator
  • CASI 12.36
  • UONEK 44.17

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: